Harnessing Metformin for Targeted Intervention: Addressing Cardiac Fibrosis in Plasminogen Activator Inhibitor-1 (PAI-1) Deficiency
Saved in:
| Main Authors: | Serena Pulente, Claire Fong-McMaster, Natasha Trzaskalski, Sweta Gupta, Magdalena Lewandowska, Amy Shapiro, Kyoung-Han Kim, Erin Mulvihill |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Journal of Molecular and Cellular Cardiology Plus |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772976125000947 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remodeling of mitochondrial supercomplex-associated proteins in murine heart failure: implications for pyruvate and alpha-ketoglutarate metabolism
by: Claire Fong-McMaster, et al.
Published: (2025-06-01) -
Plasminogen influence on the PAI-1 release by human platelets
by: O. I. Yusova, et al.
Published: (2024-06-01) -
Evaluation of Serum Fibrinogen, Plasminogen, α2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM
by: Sefika Burcak Polat, et al.
Published: (2014-01-01) -
Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1)
by: Francesco Angelucci, et al.
Published: (2025-06-01) -
Changes in the plasma level of plasminogen activator inhibitor-1 in patients with cranio-cerebral trauma depending on body weight and PAI-1 -675 4G/5G gene polymorphism
by: O. O. Potapov, et al.
Published: (2019-02-01)